Global HIV Therapeutic & Preventive Vaccines Market

Description

Introduction

One of the leading infectious disease, HIV is taking a huge death toll across the globe, surpassing malaria and TB. Therapeutic HIV vaccines are designed for patients who have HIV with the aim to improve the body’s immune response to the disease. Preventive HIV vaccine is given to people who are not suffering from HIV, with the aim of preventing HIV infection in the future. Currently, there are no therapeutic and preventive HIV vaccines approved by the Food and Drug Administration (FDA), but research is under way. Therapeutic HIV vaccines are required to slack down the progression rate of HIV infection and to eliminate the need for antiretroviral therapy (ART) while still keeping undetectable levels of HIV. Also, therapeutic HIV vaccines will be utilized as part of a larger strategy to eliminate all HIV from the body.

Market Dynamics

The Preventive and Therapeutic Vaccine Market is expected to experience high growth in the forecasted period due to various factors such as an increase in the number of infected population, expansion of research and development funding for HIV vaccines, rise in the government spending for vaccine development, introduction of faster vaccine development technologies, and improvements in vaccine design. However, the stringent regulations for the approval of vaccines, complexity associated with research studies and low success rate in clinical trials for therapeutics hamper the market expansion.

Market Segmentation

The market for Preventive and Therapeutic Vaccine is segmented on the basis of technology type and phase of research. On the basis of technology, the market is categorized into toxoid, live attenuated, conjugate, recombinant, and inactivated & subunit. The conjugate vaccines have the largest market share due to massive government support for vaccine development and rising investments in R&D. In terms of phase of research, the market is classified into Preclinical, Clinical, Phase I, II, III, IV etc.

Regional/Geographic Analysis

The Preventive and Therapeutic Vaccine Market has enormous market opportunities around the world. Currently, U.S. enjoys the major market share because of the presence of large pharmaceutical industry base, best-in-class healthcare infrastructure, and high spending on healthcare by the citizens. The presence of advanced and active R&D establishment further fuel the growth. Europe is the second largest market after North America. Research, Development and Innovation conducted by various MNCs in the field of vaccine production are advantages for this region.

Key Players

The Global Preventive and Therapeutic Vaccine Market is mainly controlled by firms such as Pfizer, Merck, Sanofi, Novartis, Profectus Biosciences, Antigen Express, Bionor Pharmaceuticals, Celldex Therapeutics, Glaxo Smith Kline, Inovio Pharmaceuticals, Crucell Pharmaceutical, AlphaVax, FIT Biotech among others. An Increase in the prevalence of diseases in children and adults will generate demand for more preventive vaccine in coming years, providing market opportunities to these firms.

Report ContentsRegional AnalysisReport Highlights
  • Market segments
  • Market Drivers, Restraints and Opportunities
  • Market Size & Forecast 2016 to 2022
  • Supply & Demand Value Chain
  • Market – Current Trends
  • Competition & Major Companies
  • Technology and R&D Status
  • Porters Five Force Analysis
  • Strategic and Critical Success Factor Analysis of Key Players
  • North America
    • US and Canada
  • Latin America
    • Mexico, Brazil, Argentina and Rest of Latin America
  • Western Europe
    • EU5 (Germany, France, Italy, Spain, U.K.)
    • Nordic Countries (Denmark, Finland, Norway, and Sweden)
    • Benelux (Belgium, The Netherlands, and Luxembourg)
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Rest of Eastern Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
    • South Africa
    • North Africa
    • Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

  • Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
  • Consumer and Pricing Analysis
  • Market dynamics of the industry
  • Market Segmentation
  • Estimated Market Sizing in terms of volume and value
  • Recent trends in Market and impact
  • Research Status and Technology Overview
  • Extensive Industry Structure Coverage

Related Products:

Global HIV Therapeutic & Preventive Vaccines Market

The vaccine market is not the same as any other product market. The vaccine market has very different characteristics that increase the complexity of price and purchasing assessment and understanding in their context. It consists of individual markets for individual vaccines or vaccine types, each with specific characteristics, in particular on the supply side. Also, the new candidates for vaccination against cancer and HIV who are under development should reach the magical stage. In the past...

Global HIV Therapeutic & Preventive Vaccines Market

The market was valued at USD 11 billion in 2017 and is projected to reach USD 51 billion by 2022, at a CAGR of 29% during the forecast period. The increasing prevalence of chronic diseases such as cancer and HIV/AIDS are the major reasons driving the market growth. These medicines helps to strengthen the immune response of the body against specific diseases. However every medicine need to be approved by FDA. Increasing cases of chronic diseases and need for effective treatment is acting as ke...

Global HIV Therapeutic & Preventive Vaccines Market

The Global Contraceptives Drugs and Devices Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 growing at a CAGR of XX% during the period of forecast. The main usage of the contraceptives drugs and devices is to control birth and pregnancies that are not intended. Various types of contraceptives drugs and devices include: methods like sterilisation, contraceptive pills, intra-uterine devices, vaginal rings, injectable, implants, combined oral contraceptives and ...

Global HIV Therapeutic & Preventive Vaccines Market

Global Dermatological Therapeutics basically caters to three problems viz. cosmetics, skin cancer and general conditions such as Acne. Current analysis of the market shows huge demand and a lesser supply, and therefore the market is and is going to undergo impressive growth in the years to come. Also, the investments and consolidation is majorly carried out by the private sector and right now, the market is fragmented among few players that will remain more or less the same. Also, the patents...

Global HIV Therapeutic & Preventive Vaccines Market

In today's world, with the growing urbanization, air pollution is one of the major reasons for concern regarding people's health concerns. One of the major diseases that is getting prevalence, mostly among the developed countries is lung cancer. This is giving rise to the therapeutics market for lung cancer. Also, the developing markets are having increasing concerns about this disease and therefore, the therapeutics market is expected to develop rapidly. End-User/Technology The end-use...

Global HIV Therapeutic & Preventive Vaccines Market

The Global Ophthalmic Drugs Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 growing at a CAGR of XX% during the forecast period . As seen, the ophthalmic industry is a rapidly growing area in today’s medical world due to the ever increasing aging population in the world. Ophthalmic drugs cover a wide range of tools and products which are used in eye surgery and curing different types of eye ailments. Ophthalmic drugs are the drugs that are used for the treat...

Global HIV Therapeutic & Preventive Vaccines Market

By 2022, the Global Precision Medicine Market is estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. Precision Medicine is an emerging medical model that proposes the customisation of healthcare, with medical decisions, practices, and products being tailored to theindividual variability in genes, environment, and lifestyle for each patient. This new approach enables doctors to better assess the patient’s disease risk, thus predicting a...

Global HIV Therapeutic & Preventive Vaccines Market

A urinary tract infection (UTI) is considered as one of the most common types of infection and is caused by microbes such as bacteria overcoming the body's defenses in the urinary tract. The urinary tract can be divided into the upper urinary tract consisting of kidneys and the ureters and the lower urinary tract that consists of the bladder and the urethra. The common symptoms include a frequent and strong urge to urinate along with a painful and burning sensation when urinating, strong odou...

Global HIV Therapeutic & Preventive Vaccines Market

Solid tumor therapeutics are those pharmaceuticals which specifically treat various types of cancers such as breast cancer, lung cancer, prostate cancer, colorectal cancer, cervical cancer and others. Solid tumors are an abnormal mass of tissue that usually does not contain cysts or liquid areas. They are of two types, namely benign and malignant. The treatment of solid tumors requires synchronized actions of many healthcare professionals, such as surgeons, radiation specialists, oncologists,...

Global HIV Therapeutic & Preventive Vaccines Market

Global Oral Care Products Market- Industry Analysis, Forecasts and Opportunity Assessment (2017-2022) Oral Health has become an indispensable part of our lives. The increasing awareness regarding oral sterility has led to many new formulations, countless number of innovative products, and other supplements that promotes oral health. Rising consciousness regarding pleasant breath and pleasing smile has led to a lot of innovation and breakthroughs in the market. The trend is likely to continue...

Global HIV Therapeutic & Preventive Vaccines Market

$3,850.0

Industry Analysis, Forecasts and Opportunity Assessment (2017-2022)

  • Market Trends, Dynamics and Regulatory Framework
  • Regional and Cross-segment Sales Figures
  • Extensive Industry Structure Coverage

Sample Report Request Customisation

Clear
SKU: N/A Category:

    
    
    	
×
Sample Report
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×
Report Customisation
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. You may contact us at any time to opt-out. Please tick here to receive these communications.
×